Keep an eye on GNLB....

Question

maybe the move up starts today.

gman1962 · Answer

maybe the move up starts today.

gman1962 · Answer

anyone listen?

wallstreetcappers · Answer

Nice job krallman!Looks good..

gman1962 · Answer

Thanks street....what is that they say about blind squirrels?&#xD;&#xA; &#xD;&#xA;lol

wallstreetcappers · Answer

If you are a blind squirrel than I need to consider doing it myself.You are kicking butt financially if I do say so..

gman1962 · Answer

another move today....as high as 2.61

wallstreetcappers · Answer

Nice move..I dont get the action lately, all the candidates arent even in trials yet which mean the company is years out from any real news..&#xD;&#xA;&#xD;&#xA;Maybe the small market cap and some bargain shopping plus that firm target helped...&#xD;&#xA;&#xD;&#xA;Good work.

TheBest · Answer

years i disagree the next twelve months the target is 6 dollars trials are starting already.

wallstreetcappers · Answer

Big$$$,12 months? I think you are underestimating the time it takes for trials and the time things take to develop even after trials.

TheBest · Answer

trials have many stages as we all know.. and the analysts agree with me

"Shares of Genelabs Technologies Inc. jumped in Thursday morning trading after an analyst began covering the biopharmaceutical company with a "Buy" rating, predicting the stock price will triple over the next 12 months.

The company has two oral hepatitis C treatments in preclinical testing, and Kevin DeGeeter of Oppenheimer & Co. was optimistic about both candidates. He believes both drugs will begin early stage testing within a year.

"Each of these drugs appears to be far more potent than competing products in late-stage clinical development and, in our view, have the potential to be best-in-class drugs," he said. "If Genelabs can successfully move one or two of these novel targets into clinical trials, we believe the company may be a compelling takeover candidate."-ap

wallstreetcappers · Answer

Big$$$,Exactly my point..the part you highlighted is my exact point.WITHIN A YEAR..that is key.how long do you think these trials take once started? How long after the trials are finished does it take to analyze data? How long after that does it take to have the community evaluate and start even sniffing towards approval?My exact point is what you highlighted..trials havent even started yet...

TheBest · Answer

well my position is that i think that the stock will move higher before the trials are completed. I believe pre clinical trials will be completed these are not phase 3 trials we are in . preclinical trials take 2 months tops analyzing data is swift because of the low amt of patients . &#xD;&#xA; &#xD;&#xA;now if that data is promising stock triples on speculation alone.. thats what i am suggesting which does happen alot in bio stocks.

wallstreetcappers · Answer

Those points are all valid, and of course the stock could go to 10, which I hope it does for krallman.POZN getting the hip check today, but the Sept options arent moving..aggravating..

TheBest · Answer

ya i like the move downward u were right there.

Keep an eye on GNLB....

Hot Forum Topics